Status:
COMPLETED
Diabetes Smoking Cessation Incentives Study
Lead Sponsor:
University of Oklahoma
Conditions:
Smoking Cessation
Diabetes Type 2
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.
Detailed Description
Type 2 diabetes (T2DM) and cigarette smoking are major causes of morbidity and mortality in US, and research indicates there is a complex relationship between these two risk factors. Smoking cessation...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes
- earn a score \> 4 on REALM indicating \> 6th grade English literacy level
- willing to quit smoking 7 days from their first visit
- have an expired CO level \>8 ppm suggestive of current smoking at baseline
- currently smoking \> 5 cigarettes per day
- willing and able to attend 6 study visits
Exclusion
- unable to demonstrate use of or unwilling to use the remote CO monitor and phone app
Key Trial Info
Start Date :
January 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04682067
Start Date
January 8 2021
End Date
April 7 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oklahoma Tobacco Research Center
Oklahoma City, Oklahoma, United States, 73104